Novel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 430-435

  Olson, Linda J ^a   Lowe, David G ^b   Drewett, James G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR RECEPTOR; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); GUANYLATE CYCLASE;

ARTICLE; CHOLESTEROL SIDE CHAIN CLEAVAGE; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; GLOMERULOSA CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ALDOSTERONE; AMINO ACID SEQUENCE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CELL LINE; CORTICOSTERONE; FORSKOLIN; GUANYLATE CYCLASE; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ATRIAL NATRIURETIC FACTOR; ZONA GLOMERULOSA;

EID: 0029789839     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Brenner, B. M., B. J. Ballerman, M. E. Gunning, and M. L. Zeidel. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70:665-669 (1990).
2. Drewett, J. G., and D. L. Garbers. The family of guanylyl cyclase receptors and their ligands. Endocr. Rev. 15:135-162 (1994).
3. Atarashi, K., P. J. Mulrow, R. Franco-Saez, R. Snajdar, and J. Rapp. Inhibition of aldosterone production by an atrial extract. Science (Washington D. C.) 224:992-994 (1984).
4. Goodfriend, T. L., M. E. Elliot, and S. A. Atlas. Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci. 35:1675-1682 (1984).
5. Maack, T., D. N. Marion, M. J. F. Camargo, H. D. Kleinhert, J. H. Laragh, E. D. Vaughan, Jr., and S. A. Atlas. Effect of auriculin (atrial natriuretic factor) on blood pressure, renal function and the renin-aldosterone system in dogs. Am. J. Med. 77:1069-1075 (1984).
6. Ganguly, A. Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s). Am. J. Physiol. 263:E181-E194 (1992).
7. Campbell, W. B., M. G. Currie, and P. Needleman. Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells. Circ. Res. 57:113-118 (1985).
8. Barrett, P. Q., and C. M. Isales. The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology 122:799-808 (1988).
9. 2+ conductance and reduces cAMP via a cGMP-independent mechanism. Am. J. Physiol. 263:C334-C342 (1992).
10. Anand-Srivastava, M. B., and G. J. Trachte. Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45:455-497 (1993).
11. MacFarland, R. T., B. D. Zelus, and J. A. Beavo. High concentrations of cGMP-stimulated phosphodiesterase mediated ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J. Biol. Chem. 266:136-142 (1991)
12. Budzik, G. P., S. L. Firestone, E. N. Bush, P. J. Connolly, T. W. Rockway, V. K. Sarin, and W. H. Holleman. Divergence of ANF analogs in smooth muscle cGMP response and aorta vasorelaxation: evidence for receptor subtypes. Biochem. Biophys. Res. Commun. 144:422-431 (1987).
13. Minamitake, Y., Y. Kitajima, M. Furuya, M. Yoshida, and S. Tanaka. Structure-activity relationships of alpha-human atrial natriuretic peptide (alpha-hANP) analogs: role of charged groups in alpha-ANP. Chem. Pharm. Bull. 39:2005-2008 (1991).
14. Oda, S., T. Sano, Y. Morishita, and Y. Matsuda. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells. J. Pharmacol. Exp. Ther. 263:241-245 (1992).
15. Ohyama, Y., K. Miyamoto, Y. Morishita, Y. Matsuda, Y. Saito, K. Kangawa, and H. Matsuo. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist. Biochem. Biophys. Res. Commun. 189:336-342 (1992).
16. Toki, S., Y. Morishita, T. Sano, and Y. Matsuda. HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells. Neurosci. Lett. 135:117-120 (1992).
17. von Geldern, T. W., G. P. Budzik, T. P. Dillon, W. H. Holleman, M. A. Holst, Y. Kiso, E. I. Novosad, T. J. Opgenorth, T. W. Rockway, A. M. Thomas, and S. Yeh. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol. Pharmacol. 38:771-778 (1990).
18. von Geldern, T. W., T. W. Rockway, S. K. Davidsen, G. P. Budzik, E. N. Bush, M. Y. Chu-Moyer, E. M. Devine, Jr., W. H. Holleman, M. C. Johnson, and S. D. Lucas. Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation. J. Med. Chem. 35:808-816 (1992).
19. von Geldern, T. W., G. P. Budzik, and T. P. Dillon. A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation. Biochem. Biophys. Res. Commun. 185:734-739 (1992).
20. Weber, W., W. Fischli, E. Hochuli, E. Kupfer, and E. K. Weibel. Anantin: a peptide antagonist of the atrial natriuretic factor (ANF). J. Antibiot. (Tokyo) 44:164-180 (1991).
21. Kashiwagi, M., T. Katafuchi, A. Kato, H. Inuyama, T. Ito, H. Hagiwara, Y. Takei, and S. Hirose. Cloning and properties of a novel natriuretic peptide receptor, NPR-D. Eur. J. Biochem. 233:102-109 (1995).
22. Cunningham, B. C., D. G. Lowe, B. Li, B. D. Bennett, and J. A. Wells. Production of an atrial natriuretic peptide variant that is specific for type A receptor. EMBO J. 13:2508-2515 (1994).
23. Rainey, W. E., I. M. Bird, and J. I. Mason. The NCI-H295 cell line: a pluripotent model for adrenocortical studies. Mol. Cell. Endocrinol. 100: 45-50 (1994)
24. Lowe, D. G., and B. M. Fendly. Human natriuretic peptide receptor-A guanylyl cyclase: hormone cross-linking and antibody reactivity distinguish receptor glycoforms. J. Biol. Chem. 267:21691-21697 (1992).
25. Schoenfeld, J. R., P. Sehl, C. Quan, J. P. Burnier, and D. G. Lowe. Agonist selectivity for three species of natriuretic peptide receptor-A. Mol. Pharmacol. 47:172-180 (1995).
26. Roskelley, C. D., K. G. Baimbridge, P. C. K. Leung, and N. Auersberg. Divergent differentiation of rat adrenocortical cells is associated with an interruption of angiotensin II-mediated signal transduction. Mol. Cell. Endocrinol. 89:79-89 (1992).
27. Lupo di Prisco, C., G. Materazzi, and B. Scattolini. Inhibition of steroidogenesis by cyanoketone. Gynecol. Invest. 2:309-315 (1971/72).
28. Aguilera, G., and K. J. Catt. Loci of action of regulators of aldosterone biosynthesis in isolated glomerulosa cells. Endocrinology 104:1046-1052 (1979).
29. Drewett, J. G., B. M. Fendly, D. L. Garbers, and D. G. Lowe. Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta. J. Biol. Chem. 270:4668-4674 (1995).
30. Koller, K. J., D. G. Lowe, G. L. Bennett, N. Minamino, K. Kangawa, H. Matsuo, and D. V. Goeddel. C-type natriuretic peptide (CNP) selectively activates the B natriuretic peptide receptor (ANPR-B). Science (Washington D. C.) 252:120-123 (1991).
31. Cozza E. N., M. F. Koecking, M. del Carmen Vila, and C. E. Gomez-Sanchez. Adrenal receptors for natriuretic peptides and inhibition of aldosterone secretion in calf zona glomerulosa cells in culture. Acta Endocrinol. 129:59-64 (1993).
32. Maack, T., M. Suzuki, F. A. Almeida, D. Nussenzveig, R. M. Scarborough, G. A. McEnroe, and J. A. Lewicki. Physiological role for silent receptors of atrial natriuretic factor. Science (Washington D. C.) 238:675-678 (1987).
33. Schiebinger, R. J., D. C. Kem, and R. D. Brown. Effect of atrial natriuretic peptide on ACTH, dibutyryl cAMP, angiotensin II and potassiumstimulated aldosterone secretion by rat adrenal glomerulosa cells. Life Sci. 42:919-926 (1988).
34. Barrett, P. Q., W. B. Bollag, C. M. Isales, R. T. McCarthy, and H. Rasmussen. Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr. Rev. 10:496-518 (1989).